Work

Supplementary Tables from Targeting Autocrine CCL5–CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity

Year: 2023
Type: supplementary-materials
Abstract: This table contains patient clinical data and auto rejection rates of 4T1 tumors.
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4361875205
Cites:
Cited by:
Related to: 10